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Abstract
Antigenic variation to evade host immunity has long been assumed to be a driving force of diversifying selection in
pathogens. Colonization by Streptococcus pneumoniae, which is central to the organism’s transmission and therefore
evolution, is limited by two arms of the immune system: antibody- and T cell- mediated immunity. In particular, the effector
activity of CD4
+ TH17 cell mediated immunity has been shown to act in trans, clearing co-colonizing pneumococci that do
not bear the relevant antigen. It is thus unclear whether TH17 cell immunity allows benefit of antigenic variation and
contributes to diversifying selection. Here we show that antigen-specific CD4
+ TH17 cell immunity almost equally reduces
colonization by both an antigen-positive strain and a co-colonized, antigen-negative strain in a mouse model of
pneumococcal carriage, thus potentially minimizing the advantage of escape from this type of immunity. Using a proteomic
screening approach, we identified a list of candidate human CD4
+ TH17 cell antigens. Using this list and a previously
published list of pneumococcal Antibody antigens, we bioinformatically assessed the signals of diversifying selection
among the identified antigens compared to non-antigens. We found that Antibody antigen genes were significantly more
likely to be under diversifying selection than the TH17 cell antigen genes, which were indistinguishable from non-antigens.
Within the Antibody antigens, epitopes recognized by human antibodies showed stronger evidence of diversifying
selection. Taken together, the data suggest that TH17 cell-mediated immunity, one form of T cell immunity that is important
to limit carriage of antigen-positive pneumococcus, favors little diversifying selection in the targeted antigen. The results
could provide new insight into pneumococcal vaccine design.
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Introduction
Diversifying selection on genes encoding pathogen antigens is a
well known effect of host immunity [1,2]. Diversifying selection
can maintain multiple alleles of a gene at appreciable frequencies
in a population [3]. Acquired immune responses provide a fitness
advantage for antigenic variants that evade immune recognition,
reducing the probability that the allele encoding the targeted
antigen will fix with a single allele. In viruses such as HIV [4,5,6]
and influenza [7,8], neutralizing antibody and cytotoxic T-
lymphocytes (CTLs) drive antigenic diversification. Strong diver-
sifying selection was also identified in major antigen genes in the
malaria parasite Plasmodium falciparum [9,10]. In bacteria, diversity
of surface structures (such as capsular polysaccharides) that are
targeted by host antibodies is thought to result from such
diversifying selection [1]. However, a few exceptions exist. Measles
virus antigens show little variation, partially because exposure to
the virus would generate polyclonal antibodies that efficiently
neutralize a broad range of antigenic variants [11]. Human T cell
epitopes of Mycobacterium tuberculosis show a substantially lower level
of sequence variation than seen in other genomic regions,
suggesting T cell immune responses might limit diversification in
the antigen genes [12]. Therefore, we hypothesized that the effect
of host immunity on diversifying selection depends on the specific
mechanism involved.
Recent studies have indicated that acquired immunity elicited
by natural exposure to Streptococcus pneumoniae includes three
distinct arms [13]: (1) type-specific, antibody-mediated immunity
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antibody-mediated immunity to pneumococcal proteins, some of
which are variable and some of which are more conserved
[15,18,19,20,21,22,23,24], and (3) CD4
+ TH17 cell- mediated,
antibody independent immunity to pneumococcal proteins and to
the cell-wall polysaccharide [15,25,26,27,28]. The first two forms
of immunity are thought to operate by the standard mechanisms of
antibody binding to surface antigens, leading to opsonophagocy-
tosis, reduced attachment and/or other mechanisms of reduced
colonization [22,29]. In the last form of immunity, antigen-specific
CD4
+ TH17 cells secrete interleukin (IL)-17A, leading to the
activation and recruitment of effector cells (neutrophils and
macrophages) that then kill pneumococci [25,30,31,32]. TH17
cell-mediated immunity primarily accelerates the clearance of
pneumococcus rather than preventing initiation of carriage [31].
Even in combination, these forms of immunity to S. pneumoniae are
imperfect. Humans can be repeatedly colonized despite the
immune responses from multiple arms.
While antibody binding is by definition specific to bacteria
bearing the target antigen, we have previously shown that the
CD4
+ TH17-based effector activity may extend beyond antigen-
expressing bacteria, accelerating the clearance of co-colonized
pneumococci that even do not bear the relevant antigen [23]. It is
unclear whether CD4
+ TH17-mediated immunity would still
create a fitness advantage for antigenic variants and thus promote
diversifying selection on the genes encoding the targets of such
immunity in S. pneumoniae.
Here we report the assessment of two hypotheses: first, a
competition assay was performed to examine whether an antigen-
negative strain shows a colonization advantage over the antigen-
positive strain in mice with antigen-specific TH17 immunity.
Second, pneumococcal genes that show signs of being under
diversifying selection were systematically identified and their
association with either Antibody antigens or TH17 antigens was
examined. The results indicate little evidence of diversifying
selection in the targets of CD4
+ TH17 cell immunity, unlike the
targets of antibody immunity.
Results
CD4
+ TH17 cell-mediated immunity to pneumococcal
carriage provides only weak selection for antigenic
variation
Immunization with a pneumococcal whole cell vaccine display-
ing a peptide from ovalbumin (OVA
323–339) delivered with cholera
toxin (CT) adjuvant results in CD4
+ TH17 cell-mediated and
antibody-independent protection against subsequent pneumococ-
cal colonization [23]. To examine whether the TH17 cell
immunity against S. pneumoniae, given its in trans clearance effect
[23], allows a competitive advantage for a non-recognizable
(antigen-negative) strain, twenty BALB/c mice were immunized
by either ovalbumin with adjuvant (OVA+CT) or adjuvant alone
(CT). The mice were challenged with a 1:1 mix of an antigen-
negative strain (AVO) and an antigen-positive strain (OVA). The
two strains were isogenic except that only the OVA strain displays
OVA
323–339 peptides that can be recognized by the ovalbumin-
induced, TH17 immunity in mice [23]. The AVO strain can be
viewed as an antigenic variant of the OVA strain and the AVO/
OVA ratio would increase if there were a competitive advantage
for the antigen-negative strain.
The mixture of pneumococci colonized the ovalbumin-immu-
nized and control mice equally well on day 1. No significant
difference in colonization density was observed (Figure 1A,
p=0.87, Mann-Whitney test). By day 4, the median colonization
density in ovalbumin-immunized mice was about 7-fold lower
than that in the control mice, although the difference was not
statistically significant (Figure 1A, p=0.48, Mann-Whitney test).
By day 8, the median colonization density in the immunized mice
was about 40-fold lower than that in the control mice and the
difference was statistically significant (Figure 1A, p=0.02, Mann-
Whitney test). The effect was consistent with an accelerated
clearance of colonization mediated by TH17 immunity [31].
TheAVO/OVA ratio remained approximately1:1inthe control
mice during the course of the experiment (Figure 1B). The medians
of log10 (AVO/OVA) were 0.185 (n=10), 20.028 (n=11), and
0.011 (n=16) on days 1, 4 and 8, respectively (Table 1), indicating
that the AVO strain was competitively neutral in the absence of
antigen-specific immunity. In the ovalbumin-immunized mice, the
medians of log10 (AVO/OVA) were 0.334 (n=8), 0.042 (n=10)
and 0.730 (n=13) on days 1, 4 and 8, respectively (Table 1). The
median log10 (AVO/OVA) was not significantly different between
the control and the immunized group on days 1, 4 or 8 (Figure 1B,
p=0.067, p=0.50, and p=0.12, respectively, Mann-Whitney test),
although there was a trend toward an increase in AVO/OVA ratio
in the immunized mice.
To better quantify the potential competitive advantage for the
antigen-negative strain, we constructed nonparametric confidence
intervals for the median of the difference in log10 (AVO/OVA)
between the immunized group and the control group (Table 1). A
median greater than 0 would indicate a competitive advantage for
the AVO strain in the immunized group. The 95% confidence
intervals for median difference in log10 (AVO/OVA) were
(20.006, 0.563), (21.437, 0.456), and (20.2319, 1.015) on days
1, 4, and 8, respectively (Table 1). Thus, the loss of an antigen was
unlikely to provide a more than 10.4-fold (1.015 log10) median
increase in competitive advantage for the AVO strain by day 8.
We also note that the increased frequency of AVO strains was
Author Summary
Streptococcus pneumoniae, or pneumococcus, is a leading
cause of morbidity and mortality in young children and
elderly persons worldwide. Current pneumococcus vac-
cines target a limited number of clinically important
serotypes, while strains with serotypes not targeted by
current vaccines are increasing in importance in both
carriage and invasive disease. As a result, there has been a
substantial interest to develop novel, cost-effective vac-
cines based on protein antigens from pneumococcus. To
this end, it is critical to understand how the human
immune system exerts selection pressures on the targeted
antigens. Two immune mechanisms targeting pneumo-
coccal protein antigens have been documented, mediated
by antibody and T cells, respectively. In this study, we
screened for pneumococcal antigens that are commonly
recognized by human CD4
+ TH17 cells. Using a mouse
model of pneumococcal colonization, we demonstrate
that TH17 cell-based immunity almost equally reduces
colonization by both an antigen-positive strain and a co-
colonizing, antigen-negative strain. Furthermore, we dem-
onstrate that the DNA sequences of TH17 cell antigens
demonstrate no detectable signs of being under selective
pressure, unlike pneumococcal antigens known to be
strong antibody targets. Thus, one form of the T cell-
mediated immunity that is important to limit carriage of
antigen-positive pneumococcus favors little diversifying
selection in the targeted antigen. These results suggest
evolution of escape from TH17 -based vaccines may be
slower than from antibody-based vaccines.
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tion (Figure 1C). In absolute CFU numbers, therefore, the relative
advantage is unlikely to be associated with much overall
superiority.
In mice that remain colonized on days 4 and 8, a negative
correlation between the AVO/OVA ratio and total CFU
recovered was observed in the immunized group (Figure 1C) but
not in the control group (Figure 1D). These results suggested that
Figure 1. The benefit of antigenic variation in CD4+ TH17 epitope is limited. BALB/c mice were immunized by either CT alone (CT) or CT and
ovalbumin (CT+OVA). All mice were challenged with a 1:1 mixture of the antigen-negative (AVO) strain and the antigen-positive (OVA) strain. The
density of intranasal colonization by pneumococcus in each mouse was determined on days 1, 4, and 8 after challenge as described in the Methods.
Total CFU counts are shown in (A). The ratio between the two strains in each mouse was determined (B). The p values were derived from Mann-
Whitney tests comparing the immunized with the control group on days 1, 4, and 8. Solid lines indicate group medians. The correlation between total
CFU and the AVO/OVA ratio is shown for the immunized mice (C) and the control mice (D) that remained colonized on days 4 (triangle) and 8
(diamond).
doi:10.1371/journal.ppat.1002989.g001
Table 1. Analysis of competitive advantage for the antigen-negative strain.
Day Group Sample size Median log10(AVO/OVA) P-value
a 95% Confidence Interval
b
1 Control n=10 0.185 0.067 (20.006, 0.563)
Immunized n=8 0.334
4 Control n=11 20.028 0.50 (21.437, 0.456)
Immunized n=10 0.0420
8 Control n=16 0.011 0.12 (20.232, 1.015)
Immunized n=13 0.730
aTwo-sided Mann-Whitney test of equal median log10 (AVO/OVA).
bNonparametric confidence interval for median of the difference in log10(AVO/OVA).
doi:10.1371/journal.ppat.1002989.t001
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period where bacterial numbers are rather low.
Identification of human CD4
+ TH17 antigens in
pneumococcus
To determine whether CD4
+ TH17 cell-mediated immunity to
S. pneumoniae affects antigenic variation in the context of human
colonization and disease, S. pneumoniae antigens recognized by
human TH17 cells were identified. CD4
+ TH 17 cells were
enriched from peripheral blood cells and IL-17A secretion in
response to pneumococcal protein pools was measured by ELISA
(see Materials and Methods, Figure S1, and Figure S2). To
identify the common antigens in the sample population of 36
healthy adults, a Mann-Whitney test was used to compare
normalized values for each pool to the normalized values for E.
coli expressing GFP. Each protein was then ranked by its
antigenicity score, which was calculated by multiplying together
the p-values resulting from the Mann-Whitney test for both pools
containing the protein, lower antigenicity scores indicating more
commonly recognized antigens. An N-terminal fragment of PtrA
(SP0641.1) was the most strongly recognized antigen in the screen
with an antigenicity score of 1.58610
217 (Figure 2B). Clones with
a score less than 0.05 were defined as the common antigens
(Table 2).
Detection of diversifying selection in pneumococcus
To evaluate genetic diversity and the underlying selection
pressure on pneumococcal proteins, we systematically examined
protein-encoding regions from the genome sequence data of 39
publicly-available pneumococcus strains for evidence of diversify-
ing selection. Based on information accompanying the genome
sequence data, the collection of strains covered 14 common
serotypes (Table S1 in Text S1). Although the strains used in our
study are not a random sample of any population and may
overrepresent clinical (invasive) isolates, the distribution of
serotype frequency in this study was reasonably consistent with
distribution reported in human carriage [33] (Figure S3).
A flowchart of the analysis is shown in Figure 3A. Open reading
frames (ORFs) that were inferred to represent the same gene in
different strains were grouped together to form an orthologous
group. A total of 2773 unique unambiguous groups were
generated by the Proteinortho4 software [34]. Sequence alignment
of genes within an orthologous group was performed using the
PRANK software [35]. Extensive sequence variation was observed
for many pneumococcal protein-encoding genes. The nucleotide
diversity for a gene ranged from 0 to 0.23 with a median of 0.0091
(Figure 3B).
To identify pneumococcal genes that show signs of being under
diversifying selection, we analyzed the non-synonymous to
synonymous substitution (dN/dS) ratio for codon sites in each
gene using the PAML package as described by Yang [36]. Signs of
being under diversifying selection were detected by a likelihood
ratio test in which a null model (dN/dS ,=1 for all codons) was
compared with an alternative model (dN/dS.1for at least one
codon), as described in the Materials and Methods. We concluded
signs of diversifying selection for a gene if the null model was
rejected at the significance level of 0.05. By this criterion, 658
genes (23.7%) showed signs of being under diversifying selection.
The subsequent Bayes Empirical Bayes (BEB) analysis [37]
identified 1410 codon sites, or 0.178% of total codon sites, to be
under diversifying selection (Figure 3C). Codon sites under
diversifying selection were enriched in cell envelope genes (Table
S2 in Text S1), consistent with that interaction with antibodies
might be a source of selection pressure on the pneumococcal
protein antigens.
A link between immune recognition and diversifying
selection
We hypothesized that if human immunity had promoted
diversifying selection in pneumococcal antigens, the antigen genes
Figure 2. Identification of antigens recognized by human TH17 cells. (A) The average of duplicate ELISA measurements of the IL-17A
concentration in the supernatant for each protein pool is displayed. The dashed line separates data points from the two dimensions of the pooled
library (see SI for details). Each pair of colored geometric data points marks the data from pools that contain the same clone. (B) The MAD score for
each pool measured in screens of enriched TH17 cells from 36 subjects was compared to the MAD score for wells containing MoDCs pulsed with E.
coli-expressing GFP using a two-tailed Mann-Whitney test. The antigenicity score for PtrA (SP0641.1), calculated by multiplying the p-values resulting
from the Mann-Whitney test of the two pools containing the clone, is also displayed.
doi:10.1371/journal.ppat.1002989.g002
Immune Mechanisms and Diversifying Selection
PLOS Pathogens | www.plospathogens.org 4 November 2012 | Volume 8 | Issue 11 | e1002989Table 2. Identification of human T-cell antigens in pneumococcus.
Antigenicity Sore Clone Function
1.58E-17 SP0641.1 Serine protease
2.55E-10 SP1839 ABC transporter; ATP-binding/permease protein
6.52E-10 SP1323 hypothetical protein
2.74E-09 SP1072 DNA primase (dnaG)
8.63E-09 SP1434 ABC transporter; ATP-binding/permease protein
1.77E-08 SP1780 oligoendopeptidase F; putative
3.85E-08 SP0264 prolyl-tRNA synthetase (proS)
9.68E-08 SP1553 ABC transporter; ATP-binding protein
3.33E-07 SP0979 oligoendopeptidase F (pepF)
3.36E-07 SP0445 acetolactate synthase; large subunit; biosynthetic type (ilvB)
3.48E-07 SP2136 choline binding protein PcpA (pcpA)
6.00E-07 SP2032 transcriptional regulator; BglG family
9.37E-07 SP1739 KH domain protein
1.68E-06 SP2216 secreted 45 kd protein (usp45)
2.32E-06 SP0475 hypothetical protein
2.92E-06 SP1976 pyruvate formate-lyase-activating enzyme (pflA)
4.92E-06 SP0266 glucosamine–fructose-6-phosphate aminotransferase; isomerizing
6.37E-06 SP0139 conserved domain protein
8.35E-06 SP1310 IS1381; transposase OrfA
1.70E-05 SP1662 ylmH protein (ylmH)
1.79E-05 SP1251 endonuclease; putative
2.03E-05 SP2029 preprotein translocase; YajC subunit (yajC-2)
4.53E-05 SP0148 ABC transporter; substrate-binding protein
4.98E-05 SP1730 hypothetical protein
8.75E-05 SP0040 hypothetical protein
1.07E-04 SP1305 hypothetical protein
1.10E-04 SP0777 hypothetical protein
1.26E-04 SP0909 conserved hypothetical protein
1.37E-04 SP0017 IS1167; transposase; degenerate
1.69E-04 SP1717 ABC transporter; ATP-binding protein
2.03E-04 SP1476 hypothetical protein
2.04E-04 SP1594 IS3-Spn1; hypothetical protein; interruption
2.21E-04 SP1774 transcriptional regulator; putative
2.85E-04 SP0471 conserved hypothetical protein
2.99E-04 SP1465 hypothetical protein
3.01E-04 SP0955 competence protein CelB (celB)
3.21E-04 SP0310 PTS system; IIC component
3.23E-04 SP0394.2 PTS system, mannitol-specific IIBC components
3.37E-04 SP1254 hypothetical protein
3.42E-04 SP0723 conserved domain protein
3.57E-04 SP1278 pyrimidine operon regulatory protein (pyrR)
3.76E-04 SP1484 transposase family protein; authentic frameshift
4.39E-04 SP0871 conserved hypothetical protein
6.77E-04 SP1740 conserved hypothetical protein
8.33E-04 SP0605 fructose-bisphosphate aldolase (fba)
8.99E-04 SP1684 PTS system; IIBC components
9.15E-04 SP1912 hypothetical protein
1.09E-03 SP0698.1 hypothetical protein
1.12E-03 SP0575 helicase; putative
Immune Mechanisms and Diversifying Selection
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Genes encoding CD4
+ TH 17 antigens were identified as described
above. Genes encoding Antibody antigens were obtained from the
list published by Giefing et al [24]. TIGR4 genes belonging to an
orthologous group of two or more genes were analyzed, including
1648 non-antigens, 48 TH17 antigens and 80 Antibody antigens.
In addition, the regions of Antibody antigens genes that included
epitopes were also noted by Giefing et al., facilitating our
comparisons of non-antigens, Antibody antigen-encoding genes,
and the epitope-containing and non-epitope-containing regions of
these antigen-encoding genes.
The average non-synonymous substitution rate (dN) of Anti-
body antigens was significantly higher than that of non-antigens
(Figure 4A; median 0.0032 vs. 0.0025; p=0.022, Mann-Whitney
test). However, there was no significant difference in dN between
TH17 antigens and non-antigens. (Figure 4A; median 0.0026 vs.
0.0025; p=0.65, Mann-Whitney test). Genes encoding Antibody
antigens also showed a significantly higher proportion of genes
Figure 3. Detection of diversifying selection in pneumococcus. (A) Schematic of the workflow showing the procedures and software used to
detect of diversifying selection in pneumococcus. (B) The distribution of nucleotide diversity (p) among pneumococcal genes. (C) A summary of
number of genes and codon sites that show sign of being under positive selection.
doi:10.1371/journal.ppat.1002989.g003
Table 2. Cont.
Antigenicity Sore Clone Function
1.33E-03 SP0257 group II intron; maturase; degenerate
1.49E-03 SP0384.1 FMN-dependent dehydrogenase family protein
1.54E-03 SP0987 hypothetical protein
1.55E-03 SP1431 type II DNA modification methyltransferase; putative
1.89E-03 SP0809 hypothetical protein
2.44E-03 SP1314 IS66 family element; Orf1
4.19E-02 SP1385 hypothetical protein
4.86E-02 SP1384 conserved hypothetical protein
4.87E-02 SP0279 conserved hypothetical protein
doi:10.1371/journal.ppat.1002989.t002
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OR=1.95, p=0.006, Fisher’s Exact test). In contrast, TH17
antigen genes showed no evidence of being under diversifying
selection (Figure 4B, OR=0.77; p=0.52; Fisher’s Exact test).
Not all codon sites within a gene need be under the same
selective force. To understand the contribution of host immunity
to diversifying selection, we were particularly interested in whether
the codon sites that did show an estimated dN/dS ratio greater
than 1 were equally distributed among antigen categories. We
found that 0.183% of the codon sites located in the non-antigen
genes showed dN/dS ratio greater than 1 (Figure 4C). For codon
sites in the CD4
+ TH 17 antigen genes, a higher fraction (0.33%,
Figure 4C) showed a dN/dS ratio greater than 1. An even higher
fraction (0.46%, Figure 4C) of the Antibody antigen codon sites
showed a dN/dS ratio greater than 1. Furthermore, within the
Antibody antigens, the regions in antibody epitopes showed a
higher density of codon sites with dN/dS greater than 1 than the
non-epitope regions (0.62% vs. 0.42%, Figure 4C). Thus, the
genomic regions that interact with antibody-mediated immunity
appeared to be more enriched for codon sites with signs of being
under diversifying selection, with a weaker signal of diversifying
selection in the CD4
+ TH17 antigens.
To account for correlations between different codon sites within
a gene and for differences in gene length that would make longer
genes more likely, by chance alone, to have sites with elevated dN/
dS ratios, we employed a generalized-estimating-equation (GEE)
model to examine the ‘‘population-averaged’’ effect of being
recognized by human immunity on the probability that a gene is
under diversifying selection [38]. Essentially, we treated the status
of each individual codon in a gene (whether or not the codon
showed sign of being under diversifying selection) as the outcome
of a repeated measurement for the status of the gene (whether or
not the gene showed sign of being under diversifying selection).
During model fitting, the covariance structure across codon sites
within a gene was treated as a nuisance parameter. The output of
the model fitting showed that being an Antibody antigen is a
highly significant predictor for being under diversifying selection
(Figure 4D; OR=2.23, p=0.0016) and being a TH17 antigen is a
weaker, and not statistically significant predictor (Fig. 4D,
OR=1.57, p=0.17). Taken together, these results indicated that
Figure 4. Antibody recognition is associated with stronger diversifying selection. (A) Box plot to compare the average non-synonymous
substitution rate (dN) of non-antigens, the Antibody antigens and CD4
+ TH17 antigens. * p,0.05, Mann-Whitney test, compared with non-antigens
(B) The fraction of genes that show evidence of being under diversifying selection in non-antigens, Antibody antigens and CD4
+ TH17 antigens. (C)
The fraction of codons with dN/dS.1 in non-antigen, the TH17 antigens, and the epitope and the non-epitope regions of the Antibody antigens. (D)
Output of a generalized-estimating-equation (GEE) analysis for the effect of antibody-recognition (Antibody Antigen) and CD4
+ TH17 cell- recognition
(TH17 Antigen) on the probability that a gene shows signs of being under diversifying selection.
doi:10.1371/journal.ppat.1002989.g004
Immune Mechanisms and Diversifying Selection
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+ TH 17
cell immunity to diversifying selection on antigen genes in S.
pneumoniae.
To examine the robustness of our results, we carried out the
analysis of diversifying selection using a different alignment
algorithm [39], as well as another evolution model proposed by
Wilson et al., which allows estimation of the dN/dS ratio in the
presence of recombination [40]. All analyses yielded qualitatively
similar results (Table S3 and Table S4 in Text S1).
Discussion
In this study, we investigated the contribution of host immunity
to the diversifying selection in S. pneumoniae. We found that CD4
+
TH17 cell-mediated immunity, elicited by exposure to pneumo-
cocci bearing a targeted antigen, cleared pneumococci that do not
bear this antigen in trans almost as efficiently as it cleared the
antigen-bearing cells. Thus, TH17 cell immunity limited the
competitive benefit of antigenic variation within a colonized host,
potentially reducing a driving force of diversifying selection.
Consistent with this notion, we found a weak, and not statistically
significant association between diversifying selection and recogni-
tion by human TH17 cell immunity. We hypothesize that this lack
of selection is due to in trans killing of antigen-negative bacteria by
innate cells recruited through TH17 cells recognition of antigen-
expressing bacteria. However, the promiscuity of CD4
+ T cell
epitope recognition [41] could also play a role as it may be more
difficult for bacteria to mutate the recognized antigens to avoid T
cell recognition. In contrast to TH17 antigens, there was a
significant association between recognition by human antibody
and diversifying selection on the antigen. These data suggest that
these two mechanisms of acquired immunity exert distinct
selection forces on their respective antigens in S. pneumoniae.
We observed that an antigen-negative (AVO)/antigen-positive
(OVA) ratio higher than 1 was associated with lower CFU in the
ovalbumin-immunized mice but not in the control mice. This
supported the antigen-specificity of the immunity recalled by the
OVA strain. In principle, there are three stages of the
pneumococcal life cycle in which escape from immunity might
be beneficial: (1) an advantage for an escape variant by mutation
or deletion of an antigen that is the target of an immune response
during infection; (2) an advantage for a variant in colonizing a host
already responding to a ‘‘wild-type’’ strain that is resident and
targeted by the host’s response; (3) an advantage for a variant in
colonizing a host that is currently uncolonized with any
pneumococcal strain, but has immunity to wild-type alleles of
the antigen from previous exposure. Cis-acting immune effectors,
such as antibodies, would be expected to provide an advantage for
a variant at all three of these stages. Our animal experiments
suggest that for CD4
+ TH17 cells, the advantage of an immune-
escape variant would be small at stages 1 and 2, because of in-trans
killing; the first stage is particularly important because this is where
a variant would likely first arise. Still, one would expect some
advantage for CD4
+ TH17 cell escape variants at the third stage –
colonization of an uncolonized but partially immune host; this
possibly may account for the weaker, less statistically convincing
evidence of enrichment for diversifying selection in CD4
+ TH17
antigens.
Escape from CD4
+ TH 17 cell immunity in our in vivo model
should be more favored than in natural settings, for two reasons.
First, we constructed a model in which the TH17 epitope was
completely deleted (and replaced with the reverse amino acid
sequence), rather than creating a point mutation; given the
promiscuity of T cell responses, many point mutations might make
little or no difference to T cell recognition. Second, natural
exposure to pneumococci would induce immunity to multiple T
cell (and antibody) antigens, so that escape from a single response
would not necessarily create a major advantage. The fact that we
saw a modest benefit of losing the sole CD4+ T cell epitope against
which the mice had been immunized argues that the benefit would
be even weaker under natural conditions.
The high throughput screen was designed to pick up the
antigens with the strongest TH17 responses in the studied sample.
This strength includes both frequency of response in the studied
population and the strength of the response within individuals.
The Mann-Whitney analysis does not allow us to define whether
an antigen was positive in any given subject. However, if we use a
different analysis method of taking antigens that induce a response
greater than 1.2 MAD above the median, we find that the most
common antigen was recognized by 47% of the subjects, with most
antigens present in 10–20% of subjects (data not shown),
indicating a reasonably broad TH17 response. We acknowledge
that there are weaker responses in these individuals that may have
not been detected, but we posit that any selective pressure on
TH17 antigens should be more robust in the strongly recognized
antigens. Since no association between signs of diversifying
selection and the human TH17 antigens we identified was found,
the observation supports our hypothesis that CD4
+ TH17 cell
immunity in humans allows minimal competitive benefit for
antigenic variation in S. pneumoniae. It is also important to note that
only antigens recognized by IL-17A secreting T cells were
identified. If the antigens recognized by different T cell lineages
are distinct [42,43], other T cells lineages may exert stronger
selective pressure depending on their mechanism of action.
We found that genomic regions that showed signs of being
under diversifying selection were enriched in the antibody antigen
genes and further enriched in the epitopes targeted by antibodies.
This finding was consistent with the conventional understanding
that avoidance of antibody-recognition can provide a substantial
competitive benefit. The magnitude of the enrichment was
consistently modest among all analyses. It is possible that multiple
ways to avoid antibody-recognition exist, reducing the dependence
on non-synonymous substitutions in the antigens. For example,
antigens can be temporarily down regulated at the expression level
to escape from host immunity, as was seen in the malaria parasite
Plasmodium falciparum [44] and suggested for meningococci under
vaccine pressure [45]. Antigens are also proteins carrying out
physiological functions for the pathogen at the same time. They
might be subjected to diversifying, purifying or other selective
forces in addition to those imposed by acquired immunity.
However, the significant association between antibody-recognition
and diversifying selection despite these putative competing
mechanisms suggested that antibodies impose a strong fitness cost
on the antigen-bearing pneumococcus. In addition, it would be
interesting to understand whether the diversifying selection differs
in selected genes according to the invasive potential and
transformability of the strain. Appropriate comparison would
require much larger samples, which we hope to investigate in
future studies.
CD4+ T subsets other than the TH17 cells, such as the IFN-c
producing TH1 cells, have been proposed to play important roles
in the control of pneumococcal invasive disease [42,43] but not, to
our knowledge, colonization. In fact, in our colonization model,
the IFN-c mediated mechanism appeared to be dispensable [31].
Our screen would not have picked up antigens that elicited CD4+
T responses unless they also stimulated IL-17A production.
Further work might address the contribution of other forms of T
cell mediated immunity to diversifying selection.
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+ TH17 cell immunity creates little
selective pressure for antigenic variation while efficiently protecting
against pneumococcal colonization, and suggest that the reason for
thislackofselectionmaybeduetoefficientintrans killing ofantigenic
variants arising within a host. It is conceivable that a vaccine
designed to induce TH17 cell immunity might limit the immune
escape of antigenic variants and result in broader and longer
protection. To this end, further research is ongoing to characterize
the major TH17 cellantigensinpneumococcusand identifymethods
for eliciting this type of immunity through vaccination [27,46].
Materials and Methods
Ethics statement
All human subjects enrolled in this study provided written
informed consent. The protocols for this study were IRB-approved
by Quorum Review, Inc.
All animal work has been conducted in compliance with the
Animal Welfare Act and the guidelines of the U.S. Public Health
Service Policy on Humane Care and Use of Laboratory Animals,
and specifically approved by the Institutional Animal Care and
Use Committee (IACUC) of Harvard Medical School. (Animal
Welfare Assurance of Compliance A3431-01 and AAALAC
Accreditation #000009, 6/19/09)
Strains and animals
The antigen-positive S. pneumoniae stain (OVA) was a serotype
6B strain 603 derivative that expressed the OVA
323–339 peptide
(ISQAVHAAHAEINEAGR) on the bacterial surface as fusion
proteins with both pneumococcal surface protein A (PspA) and
pneumolysin (Ply) [23]. To construct the antigen-negative S.
pneumoniae (AVO), the OVA coding sequence in the pspA and ply
loci of the OVA strain was replaced by a nucleotide sequence
encoding the OVA
323–339 peptide in reversed sequence (RGAE-
NIEAHAAHVAQSI) by using a Janus-cassette mediated trans-
formation protocol [47].
Wild-type, female BALB/c mice were obtained from the
Jackson ImmunoResearch Laboratories, Barr Harbor, ME. All
mice were 5 to 6 weeks old at the start of experiments and kept in a
BL2 facility.
Immunization and challenge
Ovalbumin (Sigma-Aldrich, St. Louis, MO) and cholera toxin
(CT) mucosal adjuvant (List Biological Laboratories, Compel, CA)
were purchased and stored according to the manufacturer’s
protocols. Mice were intranasally immunized twice, one week
apart, with10 mL of PBS containing 10 mg Ovalbumin plus 1 mg
CT (OVA+CT) or 1 mg CT alone (CT).
Four weeks after the second immunization, mice were
inoculated intranasally with a mix of the OVA and the AVO
strains in 10 ml of PBS containing approximately 5610
6 CFU of
each strain. On days 1 and 4 after challenge, samples from live
animals were collected by applying 10 ml of ice cold PBS to either
nostril of a mouse and collecting droplets discharged by the
animal. On day 8 after challenge, upper respiratory tract samples
were collected post mortem from retrotracheal washes of sacrificed
mice. Aliquots of sample were titered to determine the coloniza-
tion density. The remaining samples were cultured on gentamicin
plates overnight and the resulting colonies were harvested for
genomic DNA extraction.
Quantitative PCR
Genomic DNA was purified from cultures of samples collected
from animals using DNeasy Blood and Tissue kit (QIAGEN,
Valencia, CA). The OVA strain- and the AVO strain-specific
primer sets were designed based on the nucleotide sequence
difference in the pspA locus between the two strains. The quantity
of strain-specific genomic DNA in a sample was determined by
absolute quantification protocol. A standard curve was built for
each qPCR plate and was based on two replicates. All samples
were measured based on averaged value of qPCR duplicate. The
CFU ratio between the two strains was calculated by using the
absolute amount of OVA DNA and AVO DNA in the same
sample. The detection limit of AVO/OVA ratio was set as from
(16total CFU)
21 to (16total CFU). The qPCR-derived ratios
outside this range were rounded to the nearest detection limit.
Human CD4
+ TH 17 antigen screen
Approval for blood collection was obtained from the Institu-
tional Review Boards of each institution. IL-17A-secreting CD4
+
T cells were first enriched from peripheral blood cells using
negative magnetic selection of CD4
+ T cells and a previously
published IL-17A cytokine capture protocol [48]. S. pneumoniae-
specific TH17 cells were further enriched by culturing the cells
with autologous monocyte-derived dendritic cells (MoDCs) pulsed
with inactivated S. pneumoniae. IL-17A secretion from the cells was
measured after three days of co-culture with MoDCs pulsed with
E. coli expressing a previously validated 2,547 clone ORFeome
library of the S. pneumoniae TIGR4 genome [49] arrayed in pools of
four clones. Enriched cells from 36 peripheral blood samples were
screened with the pooled library (see SI for methods detail). The
results of the IL-17A ELISA were first normalized by plate by
averaging the duplicates for each well, subtracting the plate
median from each average and then dividing the result by the
median absolute deviation of the plate, yielding the MAD score for
each well in the screen. The most common antigens recognized by
the population were identified by comparing the population
response to each pool in the library to the measured responses to
the all the wells that received E. coli expressing GFP using a one-
tailed Mann-Whitney test. Each individual antigen was then
scored by multiplying the p-values from the Mann-Whitney test of
the two wells in which it was present.
Genome sequences
Genome sequence data of 39 pneumococcal strains were
retrieved from the NCBI FTP site, ftp://ftp.ncbi.nih.gov/
genomes. The collection included 14 annotated genomes and 25
draft genomes. Accession numbers of genome sequence were listed
in Table S1 in Text S1. For the annotated genomes, the
annotation and nucleotide sequence of each gene were download-
ed from the NCBI FTP site. For the draft genomes, putative
protein-encoding genes were identified by using the Glimmer3
software [50]. Orthology analysis of pneumococcal proteins was
carried out by using the Proteinortho4 software [34], which
assigned orthologous proteins from different strains into a same
orthologous group based on the reciprocal best alignment
heuristic. Cellular roles of TIGR4 genes were categorized
according to the JCVI Annotation Gene Attributes (http://cmr.
jcvi.org).
Analysis of the non-synonymous to synonymous rate
ratio (dN/dS ratio)
The gene sequences of each orthologous group were aligned
based on the amino acid sequences they encode (codon alignment)
and a gene tree was constructed using either the ClustalW software
or the PRANK software [35,39]. A likelihood ratio test was
applied to compare a null model with an alternative model of the
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as described in [37]. In the null model (nearly-neutral model), each
codon site within a gene is assumed to be either under purifying
selection (v0,1) or under neutral evolution (v1=1). In the
alternative model (positive selection model), a codon site can be
under purifying selection (v0,1), under neutral evolution (v1=1)
or under diversifying selection (v2.1). For each model, the log
likelihood value was calculated by the CodeML program from the
package PAML [36]. If the null model was rejected by the
likelihood ratio test at a significance level of 0.05, the gene
represented by the orthologous group would be considered as
being under diversifying selection. For such genes, a Bayes
Empirical Bayes (BEB) analysis implemented in the CodeML
program [36] was used to determine the particular codon sites that
were under diversifying selection.
The output file of the CodeML program included non-
synonymous substitution rate (dN) derived from pair wise sequence
comparison. The average dN for each orthologous group was
estimated by averaging over all pair wise dNs.
The dN/dS ratio for codon sites was also estimated by a method
developed by Wilson et al., which applied a population genetics
approximation to the coalescent to accommodate recombination
events [40]. The codon alignment of each orthologous group was
analyzed by Omegamap software with a prior exponential
distribution of v and a prior v mean of 1. Each codon site was
assumed to have independent v and the posterior distributions of
v were obtains by 500,000 iterations. A codon site was defined to
show evidence of being under diversifying selection if 95% of its
posterior distribution of v was above 1. A gene was considered to
show evidence of being under diversifying selection if any codon
site within the gene showed sign of being under diversifying
selection. The analyses took 3–4 weeks on a Linux cluster
comprised of 4708 processor cores.
Statistical analysis was performed by using the R package
(http://www.r-project.org). Graphs were created in Graphpad
Prism and in Microsoft Excel.
List of NCBI-Gene ID numbers for genes and proteins
mentioned in the text: 929896 (PspA), 931915 (Pneumolysin),
930590 (PtrA).
Supporting Information
Figure S1 Enrichment of S. pneumoniae-specific TH17 cells. (A)
CD4
+ T cells purified from PBMCs by magnetic sorting were
further enriched for IL-17A secreting cells through IL-17A capture
and sorting. A portion of the enriched cells and unsorted CD4
+ T
cell population were nonspecifically expanded with a-CD3/a-
CD28 antibody-coated beads for 12 days in the presence of IL-2
and then activated with PMA/ionomycin in duplicate wells. The
average IL-17A concentration in the supernatant was measured by
ELISA after three days of incubation and is plotted for each
T cell population. (B) A portion of the two T cell populations
nonspecifically expanded in part (a) were added to MoDCs that had
been pulsed for one hour with inactivated S. pneumoniae. After 12
days, both the nonspecifically activated and S. pneumoniae-pulsed
MoDC-activated T cells were added to fresh MoDCs that had been
pulsed for two hours with either S. pneumoniae or media alone and
then fixed with paraformaldehyde prior to addition of the T cells.
The IL-17A concentration in the supernatant after three days of
incubation was measured by ELISA and is displayed for each T cell
population. US=unsorted, TH17=enriched for TH17 cells,
NS=nonspecifically activated for expansion, WCV=activated
with S. pneumoniae-pulsed MoDCs for expansion. Error bars=1 SD.
(TIF)
Figure S2 Pooling strategy for the clonal library. Each set of four
consecutive plates in the clonal library were pooled with two
different methods to create a two-dimensional library. The first
dimension was created by pooling the same well in the four
consecutive plates. The second dimension was created by pooling
four consecutive rows on the same plate. The individual clone
responsible for inducing a T cell response to a pool was identified
by examining the four pools in the second dimension that contain
one of the clones present in the stimulating pool in the first
dimension. The clone that is present in a positive pool in both
dimensions of library is designated the stimulating clone.
(TIF)
Figure S3 Serotype distribution of strains analyzed in this study
is compared with what was reported for human carriage by
Bogaert et al [33]. The Spearman’s rank correlation coefficient
(rho) is shown.
(TIF)
Text S1 The file includes supplementary methods, supplementary
figure legends, table S1: genomic sequence data used in this study,
table S2: distribution of codon sites under diversifying selection,
table S3: effects of sequence alignment and evolution model on the
detection of diversifying selection, and table S4: effects of sequence
alignment and evolution model on the GEE analysis.
(DOCX)
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